SE8305157D0 - Biologiskt aktiva 2,5-piperazindionderivat, sett for framstellning derav samt farmaceutiska kompositioner innehallande desamma - Google Patents

Biologiskt aktiva 2,5-piperazindionderivat, sett for framstellning derav samt farmaceutiska kompositioner innehallande desamma

Info

Publication number
SE8305157D0
SE8305157D0 SE8305157A SE8305157A SE8305157D0 SE 8305157 D0 SE8305157 D0 SE 8305157D0 SE 8305157 A SE8305157 A SE 8305157A SE 8305157 A SE8305157 A SE 8305157A SE 8305157 D0 SE8305157 D0 SE 8305157D0
Authority
SE
Sweden
Prior art keywords
derivatives
piperazindion
preparation
pharmaceutical compositions
biologically active
Prior art date
Application number
SE8305157A
Other languages
English (en)
Other versions
SE8305157L (sv
SE466654B (sv
Inventor
E Kasafirek
J Vanzura
I Krejci
J Krepelka
A Dlabac
M Valchar
Original Assignee
Spofa Vereinigte Pharma Werke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spofa Vereinigte Pharma Werke filed Critical Spofa Vereinigte Pharma Werke
Publication of SE8305157D0 publication Critical patent/SE8305157D0/sv
Publication of SE8305157L publication Critical patent/SE8305157L/sv
Publication of SE466654B publication Critical patent/SE466654B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8305157A 1982-10-01 1983-09-23 Biologiskt aktiva 2,5-piperazindionderivat, saett foer framstaellning daerav samt farmaceutiska kompositioner innehaallande desamma SE466654B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS827012A CS231227B1 (en) 1982-10-01 1982-10-01 2,5-pierazindion derivatives

Publications (3)

Publication Number Publication Date
SE8305157D0 true SE8305157D0 (sv) 1983-09-23
SE8305157L SE8305157L (sv) 1984-04-02
SE466654B SE466654B (sv) 1992-03-16

Family

ID=5418454

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8305157A SE466654B (sv) 1982-10-01 1983-09-23 Biologiskt aktiva 2,5-piperazindionderivat, saett foer framstaellning daerav samt farmaceutiska kompositioner innehaallande desamma

Country Status (12)

Country Link
JP (1) JPS5989671A (sv)
AT (1) AT388161B (sv)
BE (1) BE897843A (sv)
CH (1) CH655929A5 (sv)
CS (1) CS231227B1 (sv)
DE (1) DE3335891C2 (sv)
FR (1) FR2533919B1 (sv)
GB (1) GB2127807B (sv)
HU (1) HU193047B (sv)
IT (1) IT1171091B (sv)
SE (1) SE466654B (sv)
YU (1) YU44751B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS277405B6 (en) * 1986-06-12 1993-03-17 Vyzk Ustav Farm Biochem Sp Peptides with 1-amino-1-cycloalkane carboxylic acid
US5182285A (en) * 1986-11-07 1993-01-26 Spojene Podniky Pro Zdravotnickou Vyrobu Cell-protective composition for preventing or treating of peptic ulcer
GB8822674D0 (en) * 1988-09-27 1988-11-02 Tate & Lyle Plc Preparation of acylated sucrose derivatives
US7202279B1 (en) * 1998-02-11 2007-04-10 Georgetown University Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
CN1246321C (zh) * 1999-12-03 2006-03-22 小野药品工业株式会社 三氮杂螺[5,5]十一烷衍生物和含其作为活性成分的药物组合物
NZ528270A (en) * 2001-03-19 2005-10-28 Ono Pharmaceutical Co Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient
JP3975226B2 (ja) 2006-01-11 2007-09-12 生化学工業株式会社 シクロアルキルカルボニルアミノ酸誘導体及びその製造方法
CA2636765C (en) * 2006-01-11 2014-03-18 Seikagaku Corporation Cycloalkylcarbonylamino acid ester derivative and process for producing the same
JP4047365B2 (ja) 2006-01-11 2008-02-13 生化学工業株式会社 シクロアルカンカルボキサミド誘導体及びその製造方法
WO2013020527A1 (en) 2011-08-11 2013-02-14 University Of Veterinary And Pharmaceutical Sciences Brno Faculty Of Pharmacy Utilization of alaptide as transdermal penetration modifier in pharmaceutical compositions for human and veterinary applications containing anti-inflammatory drugs and/or antimicrobial chemotherapeutics
WO2014019556A1 (en) 2012-08-02 2014-02-06 University Of Veterinary And Pharmaceutical Sciences Brno Faculty Of Pharmacy Alaptide : methods of effecting its solubility, membrane permeation and pharmaceutical compositions for human and/or veterinary applications
CN107903303B (zh) * 2017-11-20 2021-06-04 陕西慧康生物科技有限责任公司 一种环肽Alaptide的液相合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1459488A (en) * 1974-03-19 1976-12-22 Wyeth John & Brother Ltd Piperazinedione derivatives

Also Published As

Publication number Publication date
ATA336683A (de) 1988-10-15
YU44751B (en) 1991-02-28
BE897843A (fr) 1984-01-16
AT388161B (de) 1989-05-10
YU195283A (en) 1986-10-31
JPH0526782B2 (sv) 1993-04-19
SE8305157L (sv) 1984-04-02
FR2533919B1 (fr) 1986-10-03
GB2127807B (en) 1987-02-25
SE466654B (sv) 1992-03-16
CS701282A1 (en) 1984-01-16
IT1171091B (it) 1987-06-10
GB2127807A (en) 1984-04-18
FR2533919A1 (fr) 1984-04-06
DE3335891C2 (de) 1993-11-11
CS231227B1 (en) 1984-10-15
CH655929A5 (de) 1986-05-30
GB8324683D0 (en) 1983-10-19
IT8323058A1 (it) 1985-03-29
DE3335891A1 (de) 1984-04-05
JPS5989671A (ja) 1984-05-23
IT8323058A0 (it) 1983-09-29
HU193047B (en) 1987-08-28

Similar Documents

Publication Publication Date Title
FI882081A (fi) 2-substituerade e-fusionerade (1,2,4) triazolo(1,5-c) pyrimidiner, farmaceutiska kompositioner och deras anvaendning.
SE8305157L (sv) Biologiskt aktiva 2,5-piperazindionderivat, sett for framstellning derav samt farmaceutiska kompositioner innehallande desamma
ATE69817T1 (de) Tetraoxodiazabicyclo-(3,3,1)-nonane.
NO152047C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksom 5-(paradeuterofenyl)-5-fenylhydantoin
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
ATE34753T1 (de) Derivate von pristinamycin iib, deren herstellung und deren pharmazeutische zusammensetzungen.
OA08715A (fr) Nouveaux dérivés peptidiques à structure polyclique azotée, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FI833453A0 (fi) Terapeutiska medel
NZ223335A (en) 5-(3-alkyl-5-tert-butyl-4-hydroxyphenyl)-2amino-6h-1,3,4 thiadiazine derivatives and pharmaceutical composiiion
PT77666B (fr) Procede de preparation de nouveaux derives de la nitrosouree
SE8304545L (sv) Bensamidderivat
ES2032985T3 (es) Nuevos tripeptidos de estructura policiclica nitrogenada, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE68494T1 (de) Benzofuranderivate und diese enthaltende therapeutische mittel.
DK601888D0 (da) Anvendelse af 2-pyrimidinyl-1-piperazinderivater
ES2058874T3 (es) 1-acil-2-pirrolidinonas como mejoradores del entendimiento y memoria y composiciones farmaceuticas que las contienen.
DE3484375D1 (de) Pharmazeutische zusammenstellung fuer die prophylaxe oder behandlung von tierhaltungsketose.
ZA825653B (en) Heteroaryloxypropanolamines,processes for their preparation,and pharmaceutical compositions thereof
ZA812349B (en) Thiazole derivates, their preparation and pharmaceutical compostions containing them
SE7409378L (sv)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8305157-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8305157-3

Format of ref document f/p: F